Search results

ANSTO as a leading science research organization in Australia is committed to the ethical, humane and responsible care of animals used for scientific purposes.

Since 1962, the United Uranium Scholarship has helped promising young scientists in the field of nuclear energy extend their knowledge and expertise. In 2022, scholarships were awarded to several ANSTO researchers, including Phil Sutton.

Project members of Magnetism.

Combined users meeting highlights how ANSTO expertise and infrastructure can assist research community.

ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.

ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.

ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries and protects the environment.

This program uses ANSTO’s nuclear capabilities to identify, quantify, and monitor the mechanisms which cause, or influence the development and progression of chronic diseases.

Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

Applications are now being accepted for the Industry foundations Scholarship.

Soft X-ray experiments used to characterise new thin film topological Dirac Semimetal.

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.